Table 2. Distribution of factors defining HCAIs in 78 patients with Enterobacteriaceae infection (duplicates allowed).

HCAIs defining factors		n (%)
Hospital treatment (outpatient) within 30 days		42 (53.8)
Antibiotic therapy within 30 days		35 (44.9)
Stayed at a hospital for at least 2 days (at least 3 hospital days) within 90 days		29 (37.2)
Hospitalization within 30 days		25 (32.1)
Received an intravenous treatment within 30 days		25 (32.1)
Underwent an invasive procedure or surgery within 6 months		14 (17.9)
Transfer from a care home or long-term care facility		8 (10.3)
Immunocompromised status
	Chemotherapy or radiation therapy for a malignant tumor within 6 months after hospitalization	5 (6.4)
	Active or metastatic cancer	4 (5.1)
	Immunosuppressant	1 (1.3)
	History of solid organ or bone marrow transplantation	0 (0.0)
	HIV-positive patient	0 (0.0)
Dialysis within 30 days		2 (2.5)
Received a wound treatment within 30 days		1 (1.3)
A family member has multidrug-resistant bacterial infection		0 (0.0)

HCAIs, healthcare-associated infections; HIV, human immunodeficiency virus.